• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强 MRI 肝胆期对肝硬化小肝癌(≤ 2cm 且血供不丰富)的动态 MRI 检测的贡献。

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

机构信息

Radiology Unit, Department of Digestive Diseases and Internal Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

出版信息

Eur Radiol. 2011 Jun;21(6):1233-42. doi: 10.1007/s00330-010-2030-1. Epub 2011 Feb 5.

DOI:10.1007/s00330-010-2030-1
PMID:21293864
Abstract

OBJECTIVE

To prospectively assess the additional value of the hepatobiliary (HB) phase of Gd-EOB-DTPA-MRI in identifying and characterising small (≤ 2 cm) hepatocellular carcinomas (HCCs) undetermined in dynamic phases alone because of their atypical features, according to the AASLD criteria.

METHODS

127 cirrhotic patients were evaluated with Gd-EOB-DTPA-MRI in two sets: unenhanced and dynamic phases; unenhanced, dynamic and HB phases. Sixty-two out of 215 nodules (29%) were atypical in 42 patients (33%).

RESULTS

62 atypical nodules were reported at histology: high-grade dysplastic nodules (HGDN)/early HCC (n = 20), low-grade DN (LGDN) (n = 21), regenerative nodules (n = 17) and nodular regenerative hyperplasia (n = 4). The sensitivity, specificity, accuracy, positive and negative predictive value (PPV, NPV) were increased by the addition of the HB phase: 88.4-99.4%, 88-95%, 88-98.5%, 97-99%, and 65-97.5%, respectively. Twenty atypical nodules were malignant (32%), 19 of which were characterised only during the HB phase.

CONCLUSIONS

The HB phase is 11% more sensitive in the classification of HGDN/early HCC than dynamic MRI, with an added value of 32.5% in the NPV. The high incidence (33%) of atypical nodules and their frequent malignancy (32%) suggest the widespread employment of Gd-EOB-DTPA-MRI in the follow-up of small nodules (≤ 2 cm) in cirrhosis.

摘要

目的

前瞻性评估钆塞酸二钠增强 MRI 肝胆期(HB 期)在识别和特征描述小(≤ 2cm)肝细胞癌(HCC)中的额外价值,这些 HCC 因不典型特征而在单独使用动态期时无法确定,其依据是 AASLD 标准。

方法

127 例肝硬化患者分别接受了 Gd-EOB-DTPA-MRI 的两组检查:平扫和动态期;平扫、动态期和 HB 期。42 例患者的 215 个结节中(33%)有 62 个(29%)不典型。

结果

62 个不典型结节在组织学上报告为:高级别异型增生结节(HGDN)/早期 HCC(n=20)、低级别异型增生结节(LGDN)(n=21)、再生结节(n=17)和结节性再生性增生(n=4)。增加 HB 期后,灵敏度、特异性、准确性、阳性预测值(PPV)和阴性预测值(NPV)分别提高到 88.4-99.4%、88-95%、88-98.5%、97-99%和 65-97.5%。20 个不典型结节为恶性(32%),其中 19 个仅在 HB 期被特征化。

结论

与动态 MRI 相比,HB 期在 HGDN/早期 HCC 的分类中提高了 11%的灵敏度,NPV 的附加价值为 32.5%。不典型结节的高发率(33%)及其频繁的恶性程度(32%)表明,在肝硬化患者小(≤ 2cm)结节的随访中,广泛使用 Gd-EOB-DTPA-MRI。

相似文献

1
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.钆塞酸二钠增强 MRI 肝胆期对肝硬化小肝癌(≤ 2cm 且血供不丰富)的动态 MRI 检测的贡献。
Eur Radiol. 2011 Jun;21(6):1233-42. doi: 10.1007/s00330-010-2030-1. Epub 2011 Feb 5.
2
Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.哪种 MRI 标志物最能用于诊断非典型性肝硬化结节的恶性程度:单独肝胆期低信号,还是与其他特征相结合?钆塞酸二钠增强后分类。
J Magn Reson Imaging. 2012 Sep;36(3):648-57. doi: 10.1002/jmri.23685. Epub 2012 May 16.
3
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.肝硬化患者 Gd-EOB-DTPA MRI 上的肝细胞癌新标志、早期肝细胞癌和高级别异型增生结节:一种新的诊断算法。
Gut. 2018 Sep;67(9):1674-1682. doi: 10.1136/gutjnl-2017-315384. Epub 2018 Feb 3.
4
Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.肝硬化中102个结节的对比增强磁共振成像:与移植肝脏组织学结果的相关性
Abdom Imaging. 2013 Apr;38(2):290-6. doi: 10.1007/s00261-012-9952-9.
5
Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.钆塞酸二钠增强MRI肝胆期具有非典型强化特征和低信号的小(≤3厘米)肝脏病变在肝硬化中的特征:一篇符合STARD标准的文章
Medicine (Baltimore). 2017 Jul;96(29):e7278. doi: 10.1097/MD.0000000000007278.
6
Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.钆塞酸二钠增强 MRI 对 HCC 和异型增生结节的评估及其与 MDCT 的检测灵敏度比较。
J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.
7
Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.肝硬化患者 Gd-EOB-DPTA 增强 MRI 下不定型肝细胞结节的演变。
Radiol Med. 2018 Jul;123(7):489-497. doi: 10.1007/s11547-018-0873-8. Epub 2018 Mar 15.
8
Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.肝硬化肝脏中的局灶性病变:其在钆塞酸增强MRI中的关键作用及西方指南中的识别方法
Dig Dis. 2014;32(6):696-704. doi: 10.1159/000368002. Epub 2014 Oct 29.
9
The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.在肝细胞癌高危患者中,钆塞酸二钠增强磁共振成像肝胆期呈低强化的乏血供肝脏病变的诊断。
Acta Med Okayama. 2013;67(4):239-44. doi: 10.18926/AMO/51068.
10
Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.钆塞酸二钠增强MRI对肝细胞癌的诊断:肝胆期肿瘤强化的定量评估
Magn Reson Med Sci. 2005;4(1):1-9. doi: 10.2463/mrms.4.1.

引用本文的文献

1
Can bile excretion on Gd-EOB-MRI be used as a visual criterion for the hepatobiliary phase?钆塞酸二钠增强磁共振成像(Gd-EOB-MRI)中的胆汁排泄能否用作肝胆期的可视化标准?
Radiol Phys Technol. 2025 Mar;18(1):147-156. doi: 10.1007/s12194-024-00868-w. Epub 2024 Dec 3.
2
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.肝细胞癌管理共识指南:台湾肝癌协会和台湾胃肠病学会2023年关于监测、诊断、全身治疗及治疗后监测的更新
Liver Cancer. 2024 Feb 12;13(5):468-486. doi: 10.1159/000537686. eCollection 2024 Oct.
3

本文引用的文献

1
Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.肝细胞癌:钆塞酸增强磁共振成像的信号强度-与分子转运体和组织病理学特征的相关性。
Radiology. 2010 Sep;256(3):817-26. doi: 10.1148/radiol.10092214. Epub 2010 Jul 27.
2
Epidemiology of hepatocellular carcinoma.肝细胞癌的流行病学。
Oncology. 2010 Jul;78 Suppl 1:7-10. doi: 10.1159/000315223. Epub 2010 Jul 8.
3
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
Role of Imaging in Screening for Hepatocellular Carcinoma.
影像学在肝细胞癌筛查中的作用。
Cancers (Basel). 2024 Oct 5;16(19):3400. doi: 10.3390/cancers16193400.
4
Optimizing predictions: improved performance of preoperative gadobenate-enhanced MRI hepatobiliary phase features in predicting vessels encapsulating tumor clusters in hepatocellular carcinoma-a multicenter study.优化预测:提高术前钆贝葡胺增强 MRI 肝胆期特征预测肝癌肿瘤簇包绕血管的性能——一项多中心研究。
Abdom Radiol (NY). 2024 Oct;49(10):3412-3426. doi: 10.1007/s00261-024-04283-y. Epub 2024 May 7.
5
Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.钆贝葡胺增强 MRI 的定量信息可预测单发肝细胞癌的增殖亚型:一项多中心回顾性研究。
Eur Radiol. 2024 Apr;34(4):2445-2456. doi: 10.1007/s00330-023-10227-9. Epub 2023 Sep 11.
6
An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.基于钆塞酸增强 MRI 的亚厘米肝癌改良诊断算法。
Eur Radiol. 2023 Apr;33(4):2735-2745. doi: 10.1007/s00330-022-09282-5. Epub 2022 Dec 6.
7
[Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].扩散加权成像及肝胆特异性对比剂钆塞酸二钠在肝脏局灶性病变诊断及鉴别诊断中的应用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):737-743. doi: 10.12182/20220960205.
8
Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.磁共振成像的放射组学和列线图在小肝细胞癌微血管侵犯术前预测中的应用。
World J Gastroenterol. 2022 Aug 21;28(31):4399-4416. doi: 10.3748/wjg.v28.i31.4399.
9
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
10
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?肝细胞癌监测患者中未明确结节的肝活检可行性:活检真的是一种有用的工具吗?
J Clin Med. 2022 Jul 28;11(15):4399. doi: 10.3390/jcm11154399.
钆塞酸二钠增强磁共振成像在肝细胞癌中的应用:与组织学分级和门静脉血流的相关性。
Eur Radiol. 2010 Oct;20(10):2405-13. doi: 10.1007/s00330-010-1812-9. Epub 2010 May 19.
4
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.钆塞酸增强肝胆期磁共振成像在肝细胞癌诊断中的应用价值。
Radiology. 2010 May;255(2):459-66. doi: 10.1148/radiol.10091388.
5
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.肝胆特异性磁共振对比剂:在肝脏和胆道成像中的作用。
Radiographics. 2009 Oct;29(6):1725-48. doi: 10.1148/rg.296095515.
6
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.基于 EASL 和 AASLD 标准,血管和非血管表现对小肝细胞癌无创诊断的影响。
Am J Gastroenterol. 2010 Mar;105(3):599-609. doi: 10.1038/ajg.2009.654. Epub 2009 Nov 24.
7
Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver.鉴别肝脏结节性再生性增生和大再生性结节的临床和影像学特征。
Clin Radiol. 2009 Dec;64(12):1190-5. doi: 10.1016/j.crad.2009.07.015. Epub 2009 Oct 8.
8
Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.钆塞酸二钠增强磁共振成像与多期多层螺旋CT用于术前检测肝细胞癌的比较
AJR Am J Roentgenol. 2009 Jun;192(6):1675-81. doi: 10.2214/AJR.08.1262.
9
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.OATP1B3的表达决定了肝细胞癌中钆塞酸二钠的摄取。
J Gastroenterol. 2009;44(7):793-8. doi: 10.1007/s00535-009-0056-4. Epub 2009 Apr 29.
10
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.肝硬化患者的肝细胞癌:钆贝葡胺增强磁共振成像与64层多期CT的定性比较
Radiology. 2009 Apr;251(1):85-95. doi: 10.1148/radiol.2511080400.